Traded Nov 13 – Nov 16, 2026 · largest single transaction ~$60K
Show all 2 transactions
Nov 13, 2026~$60K · 60K sh @ $1.00
DetailsOfficial recordNov 16, 2026~$40K · 40K sh @ $1.00
DetailsOfficial record
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
MAIA · NYSE · Pharmaceutical Preparations
$1.25+0.24 (+23.76%)
Close of Nov 17, 2026, vs Nov 16 · end-of-day, not a live quote
Maia Biotechnology (MAIA) · oqro.io/stocks/MAIA · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Including 34 routine filings (option exercises, tax withholding, grants, gifts). Open-market trades only
Traded Nov 13 – Nov 16, 2026 · largest single transaction ~$60K
Nov 13, 2026~$60K · 60K sh @ $1.00
DetailsOfficial recordNov 16, 2026~$40K · 40K sh @ $1.00
DetailsOfficial recordTraded Nov 13 – Nov 16, 2026 · largest single transaction ~$81K
Nov 13, 2026~$81K · 81K sh @ $1.00
DetailsOfficial recordInsider filing
Traded Sep 30 · filed 3 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Sep 30 · filed 3 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Sep 30 · filed 3 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Sep 30 · filed 3 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Sep 30 · filed 3 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Sep 30 · filed 3 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider buying
Traded Sep 14 · filed 1 day later
Since the trade −27.3% · S&P 500 −2.8% · to Nov 16
The CEO of Maia Biotechnology paid $100K out of pocket for Maia Biotechnology shares. 1 other person at Maia Biotechnology bought some too, in the same month. Shares held went up 8% with this purchase.
Insider buying
Traded Sep 10 · filed 4 days later
Since the trade −22.9% · S&P 500 −2.4% · to Nov 16
A Maia Biotechnology director paid $50K out of pocket for Maia Biotechnology shares. 1 other person at Maia Biotechnology bought some too, in the same month. Shares held went up 5% with this purchase.
Traded Aug 26 – Aug 28, 2026 · largest single transaction ~$109K
Aug 27, 2026~$109K · 78K sh @ $1.39
DetailsOfficial recordTraded Aug 20 – Aug 24, 2026 · largest single transaction ~$16K
Aug 24, 2026~$2.4K · 1,794 sh @ $1.33
DetailsOfficial recordInsider filing
Traded Jun 30 · filed 3 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Jun 30 · filed 3 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Jun 30 · filed 3 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Jun 30 · filed 3 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Jun 30 · filed 3 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Jun 30 · filed 3 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider buying
3 insiders in a week, 7th time since 2022Traded Jun 1 · filed 1 day later
Since the trade −22.3% · S&P 500 −2.5% · to Nov 16
The CEO of Maia Biotechnology paid $101K out of pocket for Maia Biotechnology shares. 2 other people at Maia Biotechnology bought some too, in the same month. It was the first purchase in 7 months.
Insider buying
3 insiders in a week, 7th time since 2022Traded Jun 1 · filed 1 day later
Since the trade −22.3% · S&P 500 −2.5% · to Nov 16
A Maia Biotechnology director paid $100K out of pocket for Maia Biotechnology shares. 2 other people at Maia Biotechnology bought some too, in the same month. It was the first purchase in 6 months.
Insider buying
3 insiders in a week, 7th time since 2022Traded Jun 1 · filed 1 day later
Since the trade −22.3% · S&P 500 −2.5% · to Nov 16
Maia Biotechnology's Chief Scientific Officer paid $2.7K out of pocket for Maia Biotechnology shares. 2 other people at Maia Biotechnology bought some too, in the same month. It was the first purchase in over a year.
Insider filing
Traded May 29 · filed 3 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded May 29 · filed 3 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded May 29 · filed 3 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Apr 10 · filed 4 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Apr 10 · filed 4 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Apr 10 · filed 4 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Mar 31 · filed 3 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Mar 31 · filed 3 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Mar 31 · filed 3 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Mar 31 · filed 3 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Mar 31 · filed 3 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Mar 31 · filed 3 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider buying
Traded Sep 19, 2022 · filed 1,211 days later
A Maia Biotechnology director paid $10K out of pocket for Maia Biotechnology shares.
Insider filing
Traded May 1, 2024 · filed 621 days later
Gift or transfer — classified separately from trades.
44 open-market purchases and 0 open-market sales by insiders of MAIA between Feb 22, 2023 and today, placed against the company's last 4 earnings releases. The latest on file was filed Nov 7, 2023.
Nov 16, 2026~$19K · 19K sh @ $1.00
DetailsOfficial recordAug 28, 2026~$63K · 47K sh @ $1.35
DetailsOfficial recordAug 26, 2026~$12K · 8,931 sh @ $1.39
DetailsOfficial recordAug 20, 2026~$16K · 12K sh @ $1.37
DetailsOfficial recordPurchaseSale30 days before a release30 days after
| Earnings release | 30 days before | On the day | 30 days after |
|---|---|---|---|
| Nov 7, 2023 | None | None | None |
| Aug 8, 2023 | None | None | None |
| May 8, 2023 | None | None | None |
| Mar 24, 2023 | None | None | None |
Companies set trading windows, which usually close shortly before results and reopen after them, and insiders may trade under 10b5-1 plans adopted months earlier. A date alone does not show what a person knew or why they traded. Past release dates are the dates the company filed its 8-K with Item 2.02. An upcoming date, when one is mentioned, comes from the data provider's earnings calendar (Finnhub): it is not a company filing, it is not estimated by OQRO, and it may change. Open-market purchases and sales as reported on Form 4. Largest purchases around earnings, all companies